New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 13, 2014
06:05 EDTMMCMarsh & McLennan downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse downgraded Marsh & McLennan to reflect its high exposure to property & casualty insurance brokerage platform vs. higher revenue healthcare exchange revenues. Price target raised to $53 from $48.
News For MMC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
10:34 EDTMMCMarsh & McLennan boosts dividend by 11%, increases repurchase to $2B
Marsh & McLennan Companies held its annual meeting of shareholders at which the Company announced that its Board of Directors voted to increase both the Company’s quarterly cash dividend and share repurchase program. The Board of Directors increased the quarterly cash dividend by 11% from 28c to 31c per share on outstanding common stock. The dividend is payable on August 14, to shareholders of record on July 10. The Board also authorized an increase in the Company’s share repurchase program, allowing management to buy back up to $2B of the Company’s common stock going forward, which supersedes any prior authorization. Marsh & McLennan Companies Independent Chairman of the Board Lord Lang of Monkton said: “Today’s actions to increase Marsh & McLennan’s quarterly dividend and share repurchase program demonstrate the Company’s commitment to creating long-term value for shareholders. The ability to return capital to investors while also investing in growth and efficiencies is a hallmark of effective capital management.”
May 18, 2015
09:01 EDTMMCMarsh, FireEye announce collaboration to offer cybersecurity readiness service
Marsh (MMC) and FireEye (FEYE) announced a collaboration to offer clients Marsh Cyber OASIS. This service is designed to assists clients by providing an objective evaluation of their organization’s ability to detect and respond to cyber-attacks, and the strength of their technical infrastructure.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use